MILESTONE SCIENTIFIC INC. 8-K

What Happened

• Milestone Scientific Inc. filed an 8-K (April 2, 2026) reporting that on March 31, 2026 it entered into an amendment to the Amended and Restated Memorandum of Understanding dated January 13, 2026.
• The amendment (between Milestone and Innovest S.p.A., which holds certain consent/blockage rights relating to BP4 S.r.l.) revises the definitions of “Qualified Offering” and “Other Locked-Up Parties” to facilitate a potential offering by the Company. At the time referenced in the filing, BP4 was the owner of 11.31% of Milestone’s outstanding common stock.

Key Details

• Amendment date: March 31, 2026; original MOU date: January 13, 2026.
• Counterparty: Innovest S.p.A., holder of consent/blockage rights regarding BP4 S.r.l.
• BP4 ownership referenced: 11.31% of outstanding common stock.
• The amendment’s text is filed as Exhibit 10.1 and the 8-K states the description is qualified in full by that exhibit.

Why It Matters

• The change alters contractual definitions that previously affected who is locked up and what counts as a “Qualified Offering,” which can remove or change obstacles to the company conducting a securities offering.
• For investors, this is a procedural step that could enable Milestone to pursue a capital raise; the 8-K does not disclose any offering size, pricing or timing. Monitor future SEC filings for details on any actual offering or securities issuance.